News Articles

Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.

Filters
Clear all
Showing 0 of 100
Keyword Search
Open Arrow
Article Type
Open Arrow
Company
Open Arrow
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Close Icon

Mindset Pharma Receives Approval for Phase II Clinical Trial Evaluating MSP-1014 for the Treatment of Major Depressive Disorder

News
June 22, 2023
Mindset Pharma

MAPS Receives $5 Million Grant from the Steven & Alexandra Cohen Foundation

News
June 22, 2023
MAPS

PharmaTher and Vitruvias Enter Into Collaboration Agreement for Commercialization of KETARX™ (racemic ketamine) in the U.S.

News
June 20, 2023
Pharmather

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

News
June 15, 2023
Numinus

Awakn Life Sciences Announces Closing of the Second Tranche and Upsizing of Previously Announced Private Placement

News
June 15, 2023
Awakn Life Sciences

Cognetivity Neurosciences Announces Collaboration with Alzheimer's Society to Further Expand its AI Algorithms

News
May 31, 2023
Cognetivity Neurosciences

Filament Health Announces Interim Results From Phase I Clinical Trial At The University Of California San Francisco

News
May 31, 2023
Filament Health

Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study

News
May 30, 2023
Numinus

MindMed Publishes Report by Leading FDA Experts Validating MindMed’s MM-120 Drug Development Strategy

News
May 25, 2023
Mind Medicine (MindMed)

Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy

News
May 25, 2023
Numinus

Cybin Initiates First-in-Human Dosing of CYB004 in Phase 1 Clinical Trial

News
May 24, 2023
Cybin Inc.

Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital

News
May 24, 2023
Tryp Therapeutics

Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder

News
May 15, 2023
Clearmind Medicine

Optimi Health Granted Natural Health Product Site Licence By Health Canada

News
May 10, 2023
Optimi Health

Cybin Announces Last Subject Dosed in Part B of its Phase 1 CYB004-E Trial

News
May 9, 2023
Cybin Inc.

PharmaTher Holdings Submits Fast Track Application to FDA for KETARX™ (Ketamine) for the Treatment of Parkinson’s Disease

News
May 2, 2023
Pharmather

Clearmind Medicine Announces Clinical Supply Agreement for its Upcoming Clinical Trial

News
May 2, 2023
Clearmind Medicine

Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology

News
May 2, 2023
Albert Labs

Algernon Pharmaceuticals Announces Notice of Allowance for Method of Use U.S. Patent Application

News
April 18, 2023
Algernon Pharmaceuticals

Lobe Sciences, Ltd. Announces the Acquisition of Altemia(TM) & Company

News
April 18, 2023
Lobe Sciences
No results found.
There are no results with this criteria. Try changing your search.
HomeNewsCompaniesSpotlightsSubscribe
Instagram
Twitter
RSS Feed
Email Us
©XXXX Psychedelic Finance. All rights reserved.
Privacy Policy
Core One Labs Inc.
Creso Pharma
Cybin Inc.
Enveric Biosciences
Field Trip Health
Filament Health
Havn Life
Levitee Labs
MINDCURE
Mydecine Innovations Group
NeonMind Biosciences Inc.
Novamind Inc.
Numinus
Optimi Health
Pharmather
PsyBio Therapeutics
Psyched Wellness
Psyence Group
Pure Extracts Corp
Silo Wellness
The Good Shroom Co
Tryp Therapeutics
Wesana Health
Aja Ventures
Albert Labs
Algernon Pharmaceuticals
Apex Labs Ltd.
B.More
Beckley Foundation
BetterLife Pharma
Bexson Biomedical
Biomind Labs
Bionomics
Braxia Scientific Corp.
Bright Minds
CB Therapeutics
Ceruvia Lifesciences
Clairvoyant Therapeutics
Clearmind Medicine
Clexio Biosciences
Cognetivity Neurosciences
Cube Psytech
Delic
Delix Therapeutics
Diamond Therapeutics
Ehave
FSD Pharma
Fluence
Freedom to Operate
HMNC Brain Health
Horizons ETFs Management Inc.
Incannex Healthcare
IntelGenx
Irwin Naturals
Ixtlan Bioscience
Johns Hopkins Medicine
MYND Diagnostics
Mind Medicine (MindMed)
MindBio Therapeutics
Mindset Pharma
Mycotopia Therapies
Mycrodose Therapeutics
Neural Therapeutics
Ninnion
Nirvana Life Sciences
Nova Mentis Life Science
Origin Therapeutics
Osmind
Pasithea Therapeutics
Pharmala Biotech Holdings
Psilera
Psilotec Health Solutions
PsyRx
Psylo
Quantified Citizen
Reunion Neuroscience
Revitalist Lifestyle and Wellness
Revive Therapeutics
Seelos Therapeutics
Small Pharma
Telescope Innovations
TheraPsil
TripSitter
Universal Ibogaine
Wellbeing Digital Sciences
Woke Pharmaceuticals
Woven Science
ATAI Life Sciences
Awakn Life Sciences
Beckley Psytech
Compass Pathways
Doseology Sciences
EI.ventures
Eleusis
Entheon Biomedical
Gilgamesh Pharmaceuticals
GoodCap Wellness
Lobe Sciences
Lophora
MAPS